Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VAR
2226
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.78M | ﹤0.01% |
17,799
-80,895
| -82% | -$8.3M |
|
|
UCTT
2227
Ultra Clean Holdings
UCTT
$3.31B
| $1.77M | ﹤0.01% |
57,909
-179,810
| -76% | -$4.25M |
|
2228
Blue Bird Corp
BLBD
$1.92B
| $1.77M | ﹤0.01% |
+86,031
| New | +$1.55M |
|
2229
PennantPark Floating Rate Capital
PFLT
$731M
| $1.77M | ﹤0.01% |
122,027
-776
| -0.6% | -$11.1K |
|
|
VEAC
2230
DELISTED
Vantage Energy Acquisition Corp. Class A
VEAC
| $1.76M | ﹤0.01% |
179,720
-2,000
| -1% | -$19.6K |
|
2231
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.66B
| $1.76M | ﹤0.01% |
34,401
+1,334
| +4% | +$67.5K |
|
|
HSNI
2232
DELISTED
HSN, Inc.
HSNI
| $1.75M | ﹤0.01% |
44,901
-459,793
| -91% | -$17.4M |
|
2233
Ituran Location and Control
ITRN
$1.03B
| $1.74M | ﹤0.01% |
+48,368
| New | +$1.57M |
|
2234
TriplePoint Venture Growth BDC
TPVG
$217M
| $1.74M | ﹤0.01% |
+129,988
| New | +$1.73M |
|
2235
Cass Information Systems
CASS
$731M
| $1.74M | ﹤0.01% |
36,144
+30,632
| +556% | +$1.46M |
|
2236
US Physical Therapy
USPH
$1.17B
| $1.74M | ﹤0.01% |
+28,273
| New | +$1.72M |
|
|
DCM
2237
DELISTED
NTT DOCOMO, Inc.
DCM
| $1.73M | ﹤0.01% |
75,967
-11,181
| -13% | -$260K |
|
|
JWN
2238
DELISTED
Nordstrom
JWN
| $1.73M | ﹤0.01% |
+36,691
| New | +$1.7M |
|
2239
Natera
NTRA
$48.8B
| $1.73M | ﹤0.01% |
134,233
-84,990
| -39% | -$943K |
|
2240
Nabors Industries
NBR
$1.29B
| $1.73M | ﹤0.01% |
4,282
+2,234
| +109% | +$817K |
|
2241
Amtech Systems
ASYS
$266M
| $1.73M | ﹤0.01% |
144,048
+72,406
| +101% | +$729K |
|
|
KDMN
2242
DELISTED
Kadmon Holdings, Inc.
KDMN
| $1.73M | ﹤0.01% |
515,040
+390,520
| +314% | +$1.12M |
|
2243
Wabtec
WAB
$50.8B
| $1.72M | ﹤0.01% |
22,698
-9,277
| -29% | -$714K |
|
2244
CALL
AngioDynamics
ANGO
$649M
| $1.71M | ﹤0.01% |
+100,000
| New | +$1.68M |
|
2245
Fortis
FTS
$28.3B
| $1.71M | ﹤0.01% |
47,755
+23,932
| +100% | +$863K |
|
|
CBMG
2246
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $1.7M | ﹤0.01% |
159,436
-29,341
| -16% | -$278K |
|
|
VRS
2247
DELISTED
Verso Corporation
VRS
| $1.69M | ﹤0.01% |
332,246
+24,463
| +8% | +$117K |
|
2248
Eldorado Gold
EGO
$12.2B
| $1.69M | ﹤0.01% |
153,628
-261,083
| -63% | -$2.85M |
|
2249
Scansource
SCSC
$1.14B
| $1.69M | ﹤0.01% |
38,683
-9,607
| -20% | -$378K |
|
2250
PUT
iShares MSCI Spain ETF
EWP
$2.26B
| $1.69M | ﹤0.01% |
+50,000
| New | +$1.68M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.